Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ton de Vries

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
European Heart Journal. Cardiovascular Imaging|March 18, 2016
Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic coronary angiographic studyAntonis Sakellarios, Christos V Bourantas, Stella-Lida Papadopoulou, et al.
Journal of the American College of Cardiology|July 17, 2010
Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trialJoanna J Wykrzykowska, Scot Garg, Chrysafios Girasis, et al.
Cardiology Journal|September 27, 2016
Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trialMatteo Ghione, Joanna J Wykrzykowska, Stephan Windecker, et al.
Journal of the American College of Cardiology|August 2, 2014
Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: insights from the SYNTAX trialYao-Jun Zhang, Javaid Iqbal, Carlos M Campos, et al.
Heart (British Cardiac Society)|June 27, 2013
Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers TrialRoberto Diletti, Hector M Garcia-Garcia, Christos V Bourantas, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 21, 2011
Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trialJoanna J Wykrzykowska, Scot Garg, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|November 20, 2010
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stentsJosep Gomez-Lara, Hector M Garcia-Garcia, Yoshinobu Onuma, et al.
Circulation. Cardiovascular Interventions|January 6, 2011
Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the 'All-Comers' LEADERS trialJoanna J Wykrzykowska, Scot Garg, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|August 24, 2013
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trialPatrick W Serruys, Vasim Farooq, Bindu Kalesan, et al.
European Heart Journal|October 30, 2012
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trialVasim Farooq, Patrick W Serruys, Christos Bourantas, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
European Heart Journal. Cardiovascular Imaging|March 18, 2016
Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic coronary angiographic studyAntonis Sakellarios, Christos V Bourantas, Stella-Lida Papadopoulou, et al.
Journal of the American College of Cardiology|July 17, 2010
Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trialJoanna J Wykrzykowska, Scot Garg, Chrysafios Girasis, et al.
Cardiology Journal|September 27, 2016
Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trialMatteo Ghione, Joanna J Wykrzykowska, Stephan Windecker, et al.
Journal of the American College of Cardiology|August 2, 2014
Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: insights from the SYNTAX trialYao-Jun Zhang, Javaid Iqbal, Carlos M Campos, et al.
Heart (British Cardiac Society)|June 27, 2013
Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers TrialRoberto Diletti, Hector M Garcia-Garcia, Christos V Bourantas, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 21, 2011
Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the "all-comers" LEADERS trialJoanna J Wykrzykowska, Scot Garg, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|November 20, 2010
A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stentsJosep Gomez-Lara, Hector M Garcia-Garcia, Yoshinobu Onuma, et al.
Circulation. Cardiovascular Interventions|January 6, 2011
Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the 'All-Comers' LEADERS trialJoanna J Wykrzykowska, Scot Garg, Yoshinobu Onuma, et al.
JACC. Cardiovascular Interventions|August 24, 2013
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trialPatrick W Serruys, Vasim Farooq, Bindu Kalesan, et al.
European Heart Journal|October 30, 2012
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trialVasim Farooq, Patrick W Serruys, Christos Bourantas, et al.
Pageof 4